Wells Fargo & Company Dice Therapeutics, Inc. Transaction History

Wells Fargo & Company

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$25.86 - $46.71 $254,876 - $460,373	9,856 Added 152.17%	16,333 $758,000
Q1 2023 May 12, 2023	BUY	$26.05 - $32.31 $168,413 - $208,884	6,465 Added 53875.0%	6,477 $185,000
Q4 2022 Feb 13, 2023	SELL	$19.77 - $42.23 $20,560 - $43,919	-1,040 Reduced 98.86%	12 $0
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $11,946 - $18,074	798 Added 314.17%	1,052 $21,000
Q2 2022 Aug 12, 2022	SELL	$13.19 - $22.1 $36,575 - $61,283	-2,773 Reduced 91.61%	254 $4,000
Q1 2022 May 16, 2022	SELL	$14.54 - $25.02 $72,351 - $124,499	-4,976 Reduced 62.18%	3,027 $58,000
Q4 2021 Feb 14, 2022	BUY	$22.41 - $37.54 $179,347 - $300,432	8,003 New	8,003 $203,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.